https://www.selleckchem.com/products/azd6738.html
1) across all registries. Rates of pT2-4N0-2 and pT3-4N0-2 RPUC increased with tumor size. Specifically, for tumor size intervals from 0.1-1.0 cm to 9.1-10.0 cm, the pT2-4N0-2 rate ranged from 45% to 83% and the pT3-4N0-2 rate ranged from 23% to 75%, respectively (both p 0.001). In multivariable LRMs, tumor size (in 1-cm units) was an independent predictor of pT2-4N0-2 (odds ratio [OR] 1.25; p 0.001) and pT3-4N0-2 (OR 1.30; p 0.001) disease at RNU. Tumor size is a key predictor of muscle-invasive or non-organ-confined RPU
Like
Comment
Share
